Literature DB >> 16769792

Attenuated response to purified protein derivative in patients with rheumatoid arthritis.

S Nizam, P Emery.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16769792      PMCID： PMC1798192          DOI： 10.1136/ard.2005.050161

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

Review 1.  BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment.

Authors: 
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

2.  Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis.

Authors:  D Ponce de León; E Acevedo-Vásquez; A Sánchez-Torres; M Cucho; J Alfaro; R Perich; C Pastor; J Harrison; C Sánchez-Schwartz
Journal:  Ann Rheum Dis       Date:  2005-09       Impact factor: 19.103

3.  Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.

Authors:  P Emery; G S Panayi; A M Nouri
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330
  3 in total
  7 in total

1.  QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?

Authors:  Petros Efthimiou; Sunita Sood
Journal:  Ann Rheum Dis       Date:  2006-11-24       Impact factor: 19.103

2.  Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population.

Authors:  Feride Gogus; Zafer Günendi; Resul Karakus; Zeynep Erdogan; Kenan Hizel; Fatma Atalay
Journal:  Clin Exp Med       Date:  2009-12-01       Impact factor: 3.984

3.  The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients.

Authors:  Ismail Hanta; Suleyman Ozbek; Sedat Kuleci; Ali Kocabas
Journal:  Clin Rheumatol       Date:  2008-03-05       Impact factor: 2.980

4.  Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients.

Authors:  Bella Mehta; Ekaterini Zapantis; Olga Petryna; Petros Efthimiou
Journal:  Arthritis       Date:  2015-07-29

5.  Purified protein derivative test and its booster phenomenon in patients with rheumatoid arthritis.

Authors:  Mansour Salesi; Mohsen Meidani; Shirin Meshkinfar; Hurie Hashemi; Ziba Farajzadegan
Journal:  Adv Biomed Res       Date:  2015-05-08

6.  Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Authors:  Jong Wook Yun; Seong Yong Lim; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Hoon-Suk Cha; Eun-Mi Koh; Won-Jung Koh
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

7.  Identification of latent tuberculosis infection in rheumatic patients under consideration for treatment with anti-TNF-α agents.

Authors:  Jolanta Paluch-Oleś; Agnieszka Magryś; Maria Kozioł-Montewka; Arkadiusz Koszarny; Maria Majdan
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.